The Nicholas Hall Group releases cough, cold and allergy report
LONDON — After exceptional growth driven by the COVID-19 pandemic in early 2020, global CCA sales have begun to decline in Q2, according to a new report, Cough, Cold & Allergy from The Nicholas Hall Group. Citing data from Nicholas Hall’s DB6, MAT Q2 2020 growth was 3.7%, a significant drop from the 7.8% rise
